Rankings
▼
Calendar
CPRX Q4 2020 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$31M
+3.0% YoY
Gross Profit
$26M
84.3% margin
Operating Income
$9M
27.8% margin
Net Income
$11M
36.9% margin
EPS (Diluted)
$0.11
QoQ Revenue Growth
+5.8%
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$192M
Total Liabilities
$23M
Stockholders' Equity
$170M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$31M
$30M
+3.0%
Gross Profit
$26M
$26M
+1.6%
Operating Income
$9M
$8M
+7.6%
Net Income
$11M
$8M
+44.2%
← FY 2020
All Quarters
Q1 2021 →